The first in-human FIGS study was performed by Go van Dam et al. in 2011, in which they demonstrated the feasibility of FIGS to improve the visualization of malignant lesions with a tumor-specific FRα-targeting probe, which had high specificity for peritoneal metastases and left cancer-free tissue fluorescence negative [10]. The gene discussed is FOLR1; the disease is neoplasm.